Hormone Therapy: Key Points From NAMS 2017 Position Statement.

Hormone Therapy: Key Points From NAMS 2017 Position Statement. Clin Obstet Gynecol. 2018 Jun 08;: Authors: Pinkerton JV Abstract The goal of the 2017 North American Menopause Society Hormone Therapy (HT) Position Statement is to remove fear about HT and encourage individualized shared decision making, using best available evidence. Systemic HT is safe and effective for symptomatic menopausal women aged younger than 60 years and within 10 years of menopause. Special populations of early menopause, high risk for fracture, risk of breast or uterine cancer, and extended duration are discussed. With longer duration of use, periodic evaluation and reassessment of health risks are needed. Lowered doses, transdermal therapies or newer options may enhance the benefit:risk ratio for HT. PMID: 29889667 [PubMed - as supplied by publisher]
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Tags: Clin Obstet Gynecol Source Type: research